JP2023503898A5 - - Google Patents
Info
- Publication number
- JP2023503898A5 JP2023503898A5 JP2022529452A JP2022529452A JP2023503898A5 JP 2023503898 A5 JP2023503898 A5 JP 2023503898A5 JP 2022529452 A JP2022529452 A JP 2022529452A JP 2022529452 A JP2022529452 A JP 2022529452A JP 2023503898 A5 JP2023503898 A5 JP 2023503898A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- group
- aryl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025202023A JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921047986 | 2019-11-24 | ||
| IN201921047986 | 2019-11-24 | ||
| IN202021029084 | 2020-07-08 | ||
| IN202021029084 | 2020-07-08 | ||
| PCT/IB2020/061065 WO2021100029A2 (en) | 2019-11-24 | 2020-11-24 | Prodrugs of fulvestrant |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025202023A Division JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503898A JP2023503898A (ja) | 2023-02-01 |
| JP2023503898A5 true JP2023503898A5 (https=) | 2023-12-18 |
Family
ID=75980095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529452A Pending JP2023503898A (ja) | 2019-11-24 | 2020-11-24 | フルベストラントのプロドラッグ |
| JP2025202023A Pending JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025202023A Pending JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230137764A1 (https=) |
| EP (1) | EP4061376A4 (https=) |
| JP (2) | JP2023503898A (https=) |
| CN (1) | CN115151260A (https=) |
| AU (1) | AU2020386864A1 (https=) |
| CA (1) | CA3162182A1 (https=) |
| WO (1) | WO2021100029A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4422636A4 (en) * | 2021-10-29 | 2025-09-03 | Kashiv Biosciences Llc | INECTABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BREAST CANCER |
| WO2023103929A1 (zh) * | 2021-12-06 | 2023-06-15 | 江苏亚虹医药科技股份有限公司 | 氟维司群衍生物及其制备方法和医药用途 |
| EP4444318A4 (en) * | 2021-12-06 | 2026-01-28 | Amneal Pharmaceuticals Llc | COMPOUNDS FOR CANCER TREATMENT |
| CN114716496B (zh) * | 2022-04-29 | 2024-04-02 | 香港中文大学（深圳） | 氟维司群衍生物及氟维司群衍生物制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| US20140079636A1 (en) * | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| US20160060288A1 (en) * | 2013-04-18 | 2016-03-03 | Xi'anlibang Pharmaceutical Technology Co., Ltd. | Ester derivatives of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-estra-1,3,5(10)-triene-3,17beta-diol having anticancer activity and preparation method thereof |
| WO2014169456A1 (zh) * | 2013-04-18 | 2014-10-23 | 西安力邦医药科技有限责任公司 | 7-α-[9-(4,4,5,5,5-五氟戊基亚硫酰基)壬基]-雌甾-1,3,5(10)-三烯-3,17β-二醇及其衍生物的用途 |
| CN103421069A (zh) * | 2013-05-23 | 2013-12-04 | 中国海洋大学 | 氟维司群磷酸酯衍生物及其制备方法和应用 |
| EP3738594A1 (en) * | 2013-09-10 | 2020-11-18 | Madrigal Pharmaceuticals, Inc. | Targeted therapeutics having an hsp90 ligand as binding moiety |
| WO2019050850A1 (en) * | 2017-09-05 | 2019-03-14 | Primetime Life Sciences, Llc | BIGUANIDINE DERIVATIVES OF THERAPEUTIC AGENTS, AND PREPARATION METHODS AND METHODS OF USING SAME |
| JP7384903B2 (ja) * | 2018-05-24 | 2023-11-21 | ケーアイ ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー | フルベストラントのプロドラッグ |
-
2020
- 2020-11-24 EP EP20891095.0A patent/EP4061376A4/en active Pending
- 2020-11-24 WO PCT/IB2020/061065 patent/WO2021100029A2/en not_active Ceased
- 2020-11-24 US US17/779,015 patent/US20230137764A1/en not_active Abandoned
- 2020-11-24 CA CA3162182A patent/CA3162182A1/en active Pending
- 2020-11-24 CN CN202080093658.5A patent/CN115151260A/zh active Pending
- 2020-11-24 AU AU2020386864A patent/AU2020386864A1/en active Pending
- 2020-11-24 JP JP2022529452A patent/JP2023503898A/ja active Pending
-
2025
- 2025-11-21 JP JP2025202023A patent/JP2026032104A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503898A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| RU2472509C2 (ru) | Способ лечения артрита | |
| JP2011509309A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| SI3018132T1 (en) | Condensed imidazole derivatives useful as IDO inhibitors | |
| JP2019518766A5 (https=) | ||
| JP2019537605A5 (https=) | ||
| JP2013502431A5 (https=) | ||
| JP2016530259A5 (https=) | ||
| JP2019505541A5 (https=) | ||
| JP2017533968A5 (https=) | ||
| JP2021525278A5 (https=) | ||
| JP2014518882A5 (https=) | ||
| EA023500B1 (ru) | Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2019535723A5 (https=) | ||
| JP2017517565A5 (https=) | ||
| JP2016529235A5 (https=) | ||
| JP2010500962A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| RU2016151420A (ru) | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий | |
| JP2018530582A5 (https=) | ||
| JP2017504561A5 (https=) | ||
| JP2019527724A5 (https=) |